SITE Technologies will accelerate its mission to empower the real estate industry with real-time data collection and AI property condition analysis

CHICAGO, Sept. 12, 2023 — SITE Technologies, the leading innovator in asset management and data analytics technology utilizing artificial intelligence and advanced imagery capturing technologies, is excited to announce the successful completion of its Series A funding round, securing $10 million in investment. The round was led by Prologis Ventures, the investment arm for Prologis, the global leader in logistics real estate, along with technology investors DivcoWest Ventures and Protagonist.

“Managing multiple properties can be complex, and our proprietary technology enables our clients to make decisions faster, increasing ROI while optimizing performance and productivity,” said Dan Duffy, CEO of SITE Technologies. “The way property inspections are completed has been transformed, combining our state-of-the-art data capture technology with powerful data analytics, and AI, providing invaluable insights into property conditions, infrastructure, budgets, and operations.”

SITE Technologies was formed with the vision to revolutionize the real estate industry through advanced data collection and AI analysis. The SITE’s proprietary intelligence platform uses the power of AI and drones, satellites, manned aircraft and other methods to gather precise and real-time property data, significantly improving the efficiency and accuracy of a facility’s condition analysis. This round of funding will allow the company to accelerate enhancements of the AI intelligence platform and expand globally.

“We are really excited about how Site Technologies’ platform can enhance long-term value and performance for real estate properties,” said Will O’Donnell, Managing Director, Prologis Ventures. “It’s truly a game changer in the industry. Its ability to leverage AI and other capture technologies to quickly and accurately analyze critical property characteristics allows property owners to identify potential issues as well as optimize bid management processes more efficiently.”

SITE Technologies has already established itself as a trusted partner for various industries, including commercial, industrial, and retail real estate, construction, and infrastructure management. The company’s innovative approach enables clients to access critical data remotely, eliminating the need for expensive, time-consuming, and sometimes hazardous “boots on the ground’ inspections. Prologis is now expanding using SITE in all of its locations across the Americas and expanding into Europe.

About SITE Technologies:
SITE Technologies is an innovative asset management and data analytics company whose team of experts develop best-in-class technology solutions by utilizing imagery to offer our clients’ proactive, predictive, actionable data designed to extend the lifespan of their properties and save time and money. Headquartered in Chicago, SITE Technologies serves a diverse range of industries, including retail and industrial real estate, construction, infrastructure management, and more.

For media inquiries or further information, please contact:
SITE Technologies
(847) 312-4764
625 West Adams Street, 19th Floor, Chicago, IL 60661
[email protected]
www.sitetechnologies.io

SOURCE SITE Technologies

DALLAS, Sept. 12, 2023 — NexPoint, a multibillion-dollar alternative investment platform, announces it has made an initial investment in NexPoint Life Sciences II DST, a Delaware statutory trust (DST), through a fund advised by its affiliate. The investment represents 6% of the total equity available. NexPoint plans to increase the investment size, ultimately targeting 10%-12% of the total equity available. The investment aligns NexPoint’s and DST investors’ interests and underscores the firm’s commitment to the life sciences sector. The DST acquired the two properties earlier this year. The properties, located in Philadelphia, PA, are occupied by a subsidiary of Adare Pharmaceuticals, Inc., a contract development and manufacturing organization (CDMO) focused on oral dosage forms for the pharmaceutical industry.

Within life sciences, NexPoint sees CDMOs—and the manufacturing facilities they operate—as a key area of growth. NexPoint sees a significant demand in the United States for facilities that meet the standards of current good manufacturing practices (cGMP). America’s existing cGMP infrastructure cannot support the development and production needs of the life sciences industry, which is rapidly evolving with the commercialization of novel and emerging products and therapies. Other factors adding to demand for cGMP manufacturing facilities are bipartisan governmental initiatives to re-shore manufacturing and supply chains back to the United States, as well as the sector growth in healthcare that is driving commercial-scale pharmaceutical manufacturing activity. NexPoint’s co-investment in the Life Sciences II DST is driven by these industry trends, along with the predictable cash flow offered by the properties’ triple-net tenant, Adare Pharmaceuticals, Inc.

“Real estate plays a critical role in this rapidly evolving industry and can help accelerate innovation for life sciences companies at all stages of development,” said Matt McGraner, NexPoint Real Estate Advisors’ Chief Investment Officer. “As we continue to grow our life sciences platform, our investment in NexPoint Life Sciences II DST allows us to dedicate capital alongside our investor base and increase our exposure to cGMP facilities, which we believe have some of the strongest tailwinds within life sciences real estate.”

NexPoint expects to pursue additional opportunities in the cGMP space and plans to continue to invest alongside investors in future life sciences offerings.

About NexPoint

NexPoint is a multibillion-dollar alternative investment firm comprised of a group of investment advisers and sponsors, a broker-dealer, and a suite of related investment vehicles. NexPoint provides differentiated access to alternatives through a range of investment solutions, including public and private real estate investment trusts, tax-advantaged real estate vehicles, merger arbitrage and event driven strategies, other private real estate investments, closed-end funds, interval funds, and a business development company. NexPoint is based in Dallas, Texas and is part of a network of affiliates with expertise across the asset management and financial services spaces. For more information visit nexpoint.com.

Important Disclosures

Only “accredited investors” (as that term is defined in Rule 501 promulgated under the Securities Act of 1933) who meet certain minimum requirements may invest. Investing in NexPoint Life Sciences II DST interests involves a high degree of risk. Past performance does not guarantee future results. Before investing, please review the applicable offering materials, including NexPoint Life Sciences II DST’s Confidential Private Placement Memorandum as amended or supplemented from time to time, including the “risk factors” described therein.

Contacts

Media Relations
Mike Geller, Prosek Partners for NexPoint
[email protected] 

Investor Relations
Kristen Thomas, NexPoint
[email protected]

SOURCE NexPoint

SUNNYVALE, Calif., Sept. 12, 2023 — Plug and Play, the world’s largest global innovation platform, is excited to announce its partnership with Visa, a global leader in digital payments, to launch an Inclusive Fintech Accelerator. The program aims to foster diversity and inclusivity in the fintech sector by supporting and empowering diverse founders. The application process for the accelerator is currently open and will close on September 29, 2023. To apply to the accelerator, please visit the Plug and Play DRIVE website here.

Plug and Play has a commitment to promoting innovation and cultivating a diverse ecosystem through its recently launched DRIVE initiative. DRIVE (Diversity, Respect, Inclusion, Visibility, and Equity) is designed to develop, assist, and provide better access to funding for diverse founders, and educate our broader ecosystem on the importance of diversity, equity, and inclusion and how it fuels innovation. The success of this initiative will be achieved through a community-centric approach bringing together all stakeholders needed to build a thriving ecosystem for diverse founders and communities nationwide. This framework allows innovation to work as a great equalizer.

Through this partnership with Visa, the Inclusive Fintech Accelerator aims to provide an inclusive platform that addresses the unique challenges faced by diverse founders in the tech industry. The Inclusive Fintech Accelerator will offer selected founders access to strategic guidance to help grow their business, Visa products/APIs/insights, preferential review for Visa Fast Track, mentorship, customized support from industry experts, networking opportunities from Plug and Play’s ecosystem, and customized programming. Participants will be able to collaborate closely with Visa executives, tapping into their deep knowledge of the payments and financial technology sectors.

“We are thrilled to partner with Visa to launch this internal Inclusive Fintech Accelerator,” said Saeed Amidi, Founder and CEO of Plug and Play. “By combining our resources, expertise, and global networks, we can create an environment that fosters the growth and success of diverse founders in the tech industry. We believe diversity drives innovation, and this accelerator is a significant step towards creating a more inclusive ecosystem worldwide.”

“At Visa, we believe that diversity drives innovation and progress. And that by uplifting diverse founders, the communities we live and work in can better thrive,” said Marie Elise Drogo, SVP Head of Global Fintech Partnerships, Visa. “We are excited to partner with Plug and Play to launch the Inclusive Fintech Accelerator to support and uplift diverse founders.”

Founders from diverse groups in North America, including but not limited to women, people of color, and members of the LGBTQ+ community, are encouraged to apply. More information about the application process, eligibility criteria, and program details will be available on the Plug and Play website.

The accelerator program will run for a total of eight months and will culminate in Silicon Valley at Plug and Play’s bi-annual summit in June 2024.

About Plug and Play
Plug and Play is the leading innovation platform, connecting startups, corporations, venture capital firms, universities, and government agencies. Headquartered in Silicon Valley, we’re present in 50+ locations across five continents. We offer corporate innovation programs and help our corporate partners in every stage of their innovation journey, from education to execution. We also organize startup acceleration programs and have built an in-house VC to drive innovation across multiple industries where we’ve invested in hundreds of successful companies including Dropbox, Guardant Health, Honey, Lending Club, N26, PayPal, and Rappi. For more information, visit https://www.plugandplaytechcenter.com/

Contact:
Dominique Reese
Head of DE&I
Plug and Play
[email protected] 

SOURCE Plug and Play

MORRISVILLE, N.C., Sept. 12, 2023 — Sparta Biomedical Inc., a privately held medical technology company, revolutionizing osteoarthritis treatment, is pleased to announce the close of a heavily oversubscribed convertible funding round. The company is thrilled to welcome new medtech and angel investors, along with participation from previous backers, reinforcing their unwavering belief in Sparta’s mission.

The secured capital will accelerate Sparta’s preparations for the Investigational Device Exemption study preparations of its breakthrough device, Ormi. “This capital infusion is a strong testament to Sparta’s trajectory since our last financing in 2021,” said Dimitrios Angelis, Co-founder and President of Sparta Biomedical. “This accomplishment underscores the hard work and expertise of clinical and regulatory advisors, and manufacturing and lab partners. We consider ourselves fortunate to have them as partners and look forward to continuing this journey together.”

The funding round’s success can also be ascribed to the effectiveness of Sparta’s product development model. The company achieved numerous milestones with remarkable capital efficiency, requiring only a fraction of the budget typically associated with Class III device development.

Dushyanth Surakanti expanded on this sentiment, highlighting the ingenuity of the company’s CTO, Ben Wiley, and VP and Engineering Head, Demetri Siachames. “Their platform-oriented design approach to product development and manufacturing, has yielded not only the groundbreaking Ormi device at a remarkably low cost of goods but also lays the foundation for rapid and cost-efficient development of multiple devices in the future. This fundraising round further validates this competitive advantage.”

Sparta’s remarkable progress to date and the secured funding align with their strategic objective of making a meaningful difference in the lives of osteoarthritis patients. This milestone brings Sparta one step closer to delivering on its promise of a future where osteoarthritis is no longer a life-limiting condition, but one where patients can lead lives unhindered by pain.

About Sparta Biomedical:

Sparta has developed a first-of-its-kind device, Ormi™, to treat knee osteoarthritis. Ormi was granted Breakthrough Device Designation by the US FDA.

Sparta is committed to improving motion, reducing pain, and increasing the quality of life of patients with osteoarthritis.

The impact of knee osteoarthritis cannot be ignored, with a staggering 651 million people worldwide affected by this debilitating condition. The associated morbidity and cost of this disease are significant, making it crucial to find effective solutions. This is where Ormi comes in – unlike other technologies that focus on cartilage regeneration approaches which can take a long time to grow and not as strong as the original, Ormi is different. It mimics the properties of healthy human cartilage right from day one, providing an innovative and groundbreaking solution to this widespread problem.

For more information, please visit https://www.spartabiomedical.com/ 

Ormi™ is not approved by the FDA and not commercially available. It is in development. Approvals and clearances are subject to testing, results, and the FDA review process.

SOURCE Sparta Biomedical Inc

-Proceeds to fund pivotal Phase 3 trial of RBT-1, expected to initiate in Q4 2023-
-Phase 3 trial is designed as a standalone pivotal study to support a New Drug Application (NDA)-

SOUTHLAKE, Texas, Sept. 12, 2023 — Renibus Therapeutics, Inc., (“Renibus”), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio-renal and metabolic diseases, today announced the close of an extension to its Series B financing round, bringing the total amount raised to $72 million.   Renibus’ investors are comprised of existing and new investors, including leaders in the cardiac surgery community.

“Closing an upsized round with $72 million in demand is a testament to the experience and track record of the Renibus team and the unique potential of RBT-1 to act as a preconditioning agent, bringing long-overdue innovation to patients undergoing cardiac surgery,” said Frank Stonebanks, Co-CEO of Renibus.  “We remain highly encouraged by our opportunity with RBT-1 and are well positioned to execute our pivotal Phase 3 development plans.  In addition, the FDA’s alignment on our Phase 3 pivotal study and our recent Breakthrough Therapy Designation, give us great confidence to advance RBT-1 towards patients in need with the potential to create a transformative new drug category.”

Proceeds from the Series B financing will be used to advance RBT-1 through a pivotal Phase 3 trial for its lead indication of reducing the risk of post-operative complications following cardiothoracic surgery. RBT-1 (stannic protoporfin/iron sucrose) is a potent inducer of anti-inflammatory, antioxidant and iron scavenging pathways that acts as a preconditioning agent, initially being studied in cardiac surgery patients.  In February 2023, Renibus completed Phase 2 development of RBT-1, and presented the data at the American Association for Thoracic Surgery Meeting during a late-breaking session in May 2023.

Jamie A. Donadio, Chief Financial Officer of Renibus, added, “We are pleased with the tremendous enthusiasm and commitment from our investors in deploying this additional capital.  The funding provides sufficient runway to advance RBT-1 through the planned Phase 3 trial and preparation for an NDA filing.  The upsized round is also expected to enable us to selectively fund additional pipeline programs with the potential for further value creation.”  

About RBT-1

RBT-1 (stannic protoporfin/iron sucrose) is a potent inducer of anti-inflammatory, antioxidant and iron-scavenging pathways that is advancing toward Phase 3 development for its lead indication to reduce post-operative complications following cardiothoracic surgery.

The Phase 2 study of RBT-1 (NCT04564833), which was completed in February 2023, was a randomized, double-blind, multi-center, placebo-controlled trial evaluating the effect of RBT-1 in patients undergoing elective coronary artery bypass graft (CABG) and/or cardiac valve surgery.  Renibus announced positive final results from this study in May 2023, which supports the advancement of RBT-1 into a pivotal Phase 3 study.

In June 2023, RBT-1 was granted Breakthrough Therapy designation status from the U.S. FDA to reduce the risk of complications in patients undergoing cardiothoracic surgery.

In July 2023, Renibus reached agreement with the FDA on the Phase 3 program for RBT-1.

About Renibus

Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients’ lives by developing products to prevent disease progression, improve outcomes and protect against organ damage associated with cardiorenal and metabolic diseases.  Renibus’ first-in-class lead program is RBT-1, a drug that will enter a Phase 3 pivotal trial in cardiothoracic surgery in Q4 2023. RBT-3 is a novel, low molecular weight iron nanoparticle that has the potential to rapidly resolve iron deficiency and may reduce the risk of cisplatin-induced nephrotoxicity. RBT-9 (stannic protoporfin) is a potent anti-inflammatory and antioxidant drug with broad spectrum anti-viral properties. It has been investigated in a 42-patient Phase 2, randomized, placebo-controlled trial in high-risk patients with COVID-19. The data from this trial indicated the RBT-9 has the potential to significantly improve clinical outcomes in life threatening viral infections. Additional pre-clinical work is underway to help inform the clinical development strategy.

For more information, please visit the Company’s website at www.Renibus.com and engage with us on LinkedIn.

Investor and Media Contact:

Amy Conrad
Juniper Point
[email protected]
858-914-1962

Business Development Contact

Frank Stonebanks
Co-CEO, Renibus
[email protected]

SOURCE Renibus Therapeutics

ESG and carbon management leader accelerates growth with Series A fundraise led by Next Frontier Capital

BOULDER, Colo., Sept. 12, 2023 — Optera, a leader in ESG and carbon management software, today announced $12M in Series A funding led by Next Frontier Capital with participation from Blackhorn Ventures, Mucker Capital, Overture, Engage, Massive, SaaS Ventures, Valo Ventures, AngelList, and Stout Street Capital. Optera delivers carbon management software that enables companies to reduce the climate impacts of their operations, supply chains, and products.

This funding comes at a pivotal time in the sustainability sector as the SEC and EU are establishing climate disclosure rules and businesses across the globe are seeking solutions to help decarbonize and derisk their operations and value chains over the coming decade.

“The biggest businesses around the globe are actively transitioning to the low-carbon economy. It is no longer a question of whether this transition will happen but whether it will happen quickly enough. Optera’s platform enables global companies to quantify and manage their biggest sources of emissions with greater accuracy, confidence, and actionability,” said Tim Weiss, co-founder and CEO of Optera. “We are proud to have Next Frontier Capital as a returning investor who, along with new partners, will enable Optera to scale our solution at the rate necessary to support the global transition to the low-carbon future.”

Optera offers an ESG and carbon management platform that enables companies to follow through on bold climate action. The platform currently tracks emissions associated with more than $180 billion in supply chain spend. Optera connects customers to their value chain and provides expert, tailored support informed by decades of experience.

“Optera plays an important role in Zayo’s plan to achieve net zero emissions by 2030,” said Mike Nold, EVP of Corporate Development & Strategy for Zayo, a leading global communications infrastructure provider. “With Optera’s help in emissions data collection and analysis, we completed our scope 1, 2 and 3 emissions reporting for calendar year 2021 and improved our CDP score. With Optera’s leading software solution to streamline such data collection and analysis, Zayo has greater confidence that we’re on the leading edge and making the ESG strides we’ve committed to – backed up by data our stakeholders can trust.”

Through work with partners such as the Responsible Business Alliance, the company is poised to scale its impact across sector-wide networks. Last year, the company grew its team by more than 250% and quadrupled its number of customers. Corporations like Dell and Williams Sonoma trust Optera to propel their meaningful climate action forward.

“Optera is driving innovation and change in ESG, making it easier for corporations to manage their decarbonization journey more effectively – especially across their value chains,” said Kirsten Suddath, general partner at Next Frontier Capital. “By making emissions data actionable, Optera is instilling confidence in its customers that they can report accurately and make progress towards net-zero initiatives. We see tremendous value in Optera’s solutions, which is why we have increased our investment and will continue to be a partner in their future growth.”

Adrian Tuck, former CEO of clean energy technology provider Uplight, will join the board to support Optera’s further growth and development.

“I believe Optera is positioned to be one of the biggest and most impactful startups to come out of Colorado,” said Tuck. “The quality of the Optera team and their technology has positioned them to lead the ESG software market and directly influence how the corporate sector achieves net zero emissions.”

The Series A funding will allow Optera to accelerate its product innovation and grow the sales and marketing teams to reach a global scale. In addition to new board member Tuck, who brings a wealth of experience growing successful software companies, Blackhorn Ventures Managing Partner Melissa Cheong will formally move into a board role, bringing with her extensive cleantech investing experience.

To learn more about Optera, visit opteraclimate.com.

About Optera
Optera is the ESG software for bold climate action. Built on decades of sustainability expertise, Optera helps corporations worldwide reduce their environmental impact by providing credible carbon accounting for Scope 1, 2, and 3 emissions, actionable insights and forecasts, and tools to collaborate with supply chain and investment partners. Our clients lead many of the world’s most established and ambitious corporate sustainability programs, from Dell and HPE to Grove Collaborative and Williams-Sonoma. Optera also partners with leading NGOs such as BSR, CDP, and the World Economic Forum to advance corporate ESG practices globally. Optera is registered as a Public Benefit Corporation in the State of Delaware.

Media Contact
Sam Perry
BLASTmedia for Optera
317.806.1900 x152
[email protected]

SOURCE Optera

Continues BV’s 40-year History of Investing In The North American Middle Market

BOSTON, Sept. 12, 2023 — BV Investment Partners (BV), a private equity firm focused on the tech-enabled business services, software and IT services sectors, announced today that it has completed fund raising for BV Investment Partners Fund XI at its hard cap of $1.75 billion, exceeding its target of $1.5 billion.

Consistent with its predecessor funds, Fund XI will continue BV’s proven strategy of investing alongside founders, management, and families to grow businesses. The Fund has committed to seven platform investments to date. Since its founding in 1983, the firm has generated over $9.8 billion of total value and invested in 117 platform companies across 11 funds. BV raised Fund X in 2020 with $1.1 billion of commitments.

Vikrant Raina, Chief Executive Officer and Managing Partner of BV, said, “We are grateful to our existing and new investors for their exceptionally strong support. We also want to thank the thousands of portfolio company stakeholders who are collaborating with us every day to build impactful technology solutions businesses. As we begin our fifth decade we look forward to leveraging our deep industry experience to capitalize on exciting tech-driven middle market opportunities. Fund XI is already off to a great start with seven exceptional platform investments committed in the portfolio and several exciting new opportunities in the pipeline.”

Fund XI’s investor base includes a broad range of leading global sovereign wealth funds, foundations, public and corporate pension plans, financial institutions, family offices and individual investors, including management of portfolio companies.

Maggie Carter, President and Chief Operating Officer, said, “Faced with strong headwinds in the current fundraising environment, I believe the successful outcome of the Fund XI capital raise is a testament to the Firm’s consistency in strategy, team and performance. We are thrilled almost all of our existing investors have chosen to invest with BV again in our latest fund, with nearly 75% of the capital raised in Fund XI coming from existing relationships. We also continued to diversify our LP base with the addition of new high quality institutional investors across the globe. We are a Firm that highly values its partnerships with our management teams and investors. Our goal now is to deliver on the performance expected of us in Fund XI. With a strategy that has succeeded through multiple economic cycles coupled with significant investments to the team over the last year, we believe we are in a great position to achieve this goal.”

Evercore served as Placement Agent for the fund and Ropes & Gray LLP provided legal counsel.

About BV Investment Partners

BV Investment Partners is one of the oldest and most experienced sector-focused private equity firms in North America. Since its founding in 1983, the firm has invested approximately $4.8 billion, actively targeting investments in the tech-enabled business services, software, and IT services industries. BV was ranked in Inc. magazine’s 2022 list of Founder-Friendly Investors. For more information, visit www.bvlp.com.

Contact: Chris Tofalli
Chris Tofalli Public Relations, LLC
914-834-4334

SOURCE BV Investment Partners

Co-led by Greenfield Partners and 83North, the new funding will further accelerate the company’s growth in delivering unparalleled global connectivity solutions

LONDON, Sept. 12, 2023 — floLIVE, creator of the world’s first and largest hyperlocal global cellular network and a leading provider of global connectivity, network and Connectivity Management Platforms for IoT, announced today that it has raised $47M in a Series C round of funding. The round was co-led by Greenfield Partners and existing investor 83North, with Qualcomm Ventures, Dell Technologies Capital, Saban Ventures, and Hazelnut Partners participating in the round.

floLIVE will use the funds to increase its global footprint by partnering with additional MNOs, expand its unique multi-IMSI over eSIM technology, launch an integrated satellite connectivity offering and introduce new and innovative solutions to the market such as advanced location-based applications, network-based cybersecurity services, secure data routing and more.

The global connectivity market has dramatically changed over the last few years, with OEMs and global enterprises becoming more knowledgeable and more demanding in their global IoT connectivity needs. The need for a modern, highly available global connectivity solution that enables real-time visibility, customization of network behaviour, cybersecurity protection and regulatory compliance has become a mandatory requirement.

At the same time, Mobile Network Operators (MNOs) who relied on legacy, consumer-oriented platforms are now seeking modern, cloud-based solutions that will not only adhere to the requirements introduced by those global enterprises in a cost-effective way but will also turn their IoT business into a profitable one by generating new business opportunities and achieving better unit economics. Furthermore, they are looking for ways to move away from an over-reliance on roaming agreements, which do not suit all IoT use cases and may be challenged by the wide eSIM adoption.

floLIVE’s unique hyperlocal global network spans across all continents and offers localized connectivity in a streamlined manner. This one-of-a-kind globally distributed and API-driven cellular data network serves as the underlying infrastructure for enterprises, OEMs, IoT Service Providers and MNOs – all who benefit from a modern carrier-grade, secure, robust platform that allows them to build a profitable IoT business while introducing new revenue sources and sophisticated value-added services.

floLIVE’s solutions are based on a unique, advanced, cloud-native software architecture that reduces time to market, guarantees low TCO and provides an unprecedented degree of flexibility. These offerings facilitate high performance and prolonged battery life for LPWA and broadband use cases.

“We look for highly differentiated infrastructure technologies that can support a robust and modern technology stack on top of them”, said Avery Schwartz, Partner at Greenfield Partners. “After tracking the company and space for some time, floLIVE’s rapid growth adds to our conviction that the company has developed a unique solution that elegantly solves for the full matrix of pain points traditionally plaguing the IoT connectivity market. This solution lays the foundation for new and innovative services that will dramatically change the IoT space as we know it; we are delighted to join floLIVE’s promising journey.”

“The value of floLIVE’s offering becomes increasingly clear when global enterprises are looking for a truly unified, sophisticated global connectivity solution and MNOs are searching for more robust and profitable technology partners,” said Yoram Snir, Partner at 83North.

With floLIVE, clients enjoy full management, control and visibility of every network element while supporting all use cases – from one carrier-grade global platform.

“This is a really strong vote of confidence from our existing investors as well as new investor Greenfield Partners, reiterating the value of our solution, especially during a tough economic climate where technology investments have been decreasing substantially,” said Nir Shalom, CEO, floLIVE. “We have already transformed the landscape of global IOT connectivity with our hyperlocal, global platform that addresses the needs of both OEMs and MNOs. We’re excited to use this investment to increase our global footprint and deliver more value to our customers.”

About floLIVE
floLIVE operates the first and largest hyperlocal global cellular data network, based on local POPs in dozens of locations worldwide. With the largest global connectivity library of its kind, we provide centrally managed, localized connectivity for any device, anywhere. Global means no limits on where you do business; local means low latency, high performance, and full compliance. Our network has been designed to comply with the emergence of privacy acts, data regulations and roaming restrictions. Best of all, we provide direct access to our network, that lets you control your connectivity as if you were the carrier. Monitor your devices, access real-time network events and usage, switch operators remotely, and troubleshoot failures ahead of time, so your devices never miss a beat. For more information, visit www.flolive.net.

About Greenfield Partners
Greenfield Partners is an investment firm focused on exceptional early growth stage technology businesses. With a dual presence in Tel Aviv and New York, the Greenfield team fuses deep local Israeli roots and an expansive global network to support entrepreneurs in their quest to build thriving technology companies. For more information, please visit http://greenfield-growth.com.

About 83North
83North is a global venture capital firm with over $2.2B under management. The fund invests across all stages, in exceptional entrepreneurs, whose focus is to build global category leading companies.

For more information visit www.83north.com and follow us on Twitter @83NorthVC.

Photo – https://mma.prnewswire.com/media/2207021/flolive.jpg
Logo – https://mma.prnewswire.com/media/2202905/4265979/floLIVE_Logo.jpg

SOURCE floLIVE

VICTORIA, Seychelles, Sept. 12, 2023 — Bitget, top crypto derivatives and copy trading exchange, has announced the establishment of the Bitget EmpowerX Fund. The new fund will be dedicated to fostering the platform’s ecosystem development, which will seek investment opportunities in regional exchanges, data analytics firms, media organizations and other entities that contribute to the growth of its ecosystem.

The EmpowerX Fund will invest with a capital base of $100 million, signaling Bitget’s ambitious vision. These resources will be strategically and selectively invested to maximize the company’s long-term impact in the digital assets space and its ecosystem. Bitget believes that the key to expanding the native ecosystem lies in diversifying services to cater to the varied demands of the global user base. From a strategic perspective, Bitget aims to broaden its business horizons, creating a comprehensive trading ecosystem encompassing trading, investment, research, DeFi, media, and other functions.

“The CEX landscape is continually evolving amid influences of tightened regulations, rapid growth of Layer 2 and DeFi technologies, and we are expecting that more investment, meager and acquisition will happen in the following months. Our vision goes beyond the present. With the launch of the Bitget EmpowerX Fund, we take another major step in our mission to develop Bitget into a truly comprehensive platform for all needs. Through strategic, targeted investments that foster long-term growth, we aim to continually expand our ecosystem of services to better serve the evolving needs of users. We also want to empower other people in our industry, because a rising tide lifts all boats.” as Gracy Chen, the Managing Director of Bitget, commented on the launch of the EmpowerX Fund.

For years now, Bitget has been on a relentless journey to evolve alongside the ever-changing crypto world. As both an industry and community, we have remained dedicated to supporting the development of the next generation of innovation, the latest being the launch of the $100 Million Web3 Fund in April of 2023. The fund focuses on identifying VCs and projects globally, while prioritising Asia-based partners with a clear roadmap and innovations driven to solving real-world problems. The VCs the Bitget Web3 Fund has invested in are Foresight Ventures, Dragonfly Capital, SevenX Ventures, Gitcoin Fund, DAO Maker, and ABCDE Capital.

Bitget is actively pushing forward its decentralized strategies. Bitget announced a $30 million investment in the decentralized BitKeep multi-chain wallet in March, which was later rebranded into the Bitget Wallet. This move makes Bitget the controlling stakeholder in the wallet, marking a significant step forward in the decentralized space.

On the other hand, Bitget is also strengthening its competitive edges in the centralized domain. It continuously optimizes trading experience, enriches product matrix and steps up membership cultivation efforts. The new “Trade smarter” rebranding philosophy now underpins Bitget’s market direction, emphasizing its dedication to empowering individuals with intuitive tools for a secure, user-friendly, and efficient financial future. The exchange intends to continue developing its native ecosystem, adding new products and features to maintain user interest and drive new engagements.

About Bitget

Established in 2018, Bitget is the world’s leading cryptocurrency exchange that offers Copy Trading services as one of its key features. Serving over 20 million users in more than 100 countries and regions, the exchange is committed to helping users trade smarter by providing a secure, one-stop trading solution. Bitget inspires individuals to embrace crypto through collaborations with credible partners, including legendary Argentinian footballer Lionel Messi and official eSports events organizer PGL.

For more information, visit: Website  |  Twitter  |  Telegram  |  LinkedIn  | Discord

SOURCE Bitget